abstract |
Provided herein are antibodies, or antigen-binding portions thereof, that specifically bind to and inhibit TREM-1 signaling. Also provided herein is the use of such antibodies, or antigen-binding portions thereof, in therapeutic applications such as the treatment of autoimmune diseases. |